Posology, efficacy, and safety of epidermal growth factor eye drops in 305 patients: logistic regression and group-wise odds of published data.
about
Human Serum Eye Drops in Eye Alterations: An Insight and a Critical AnalysisTargeting growth factor supply in keratopathy treatment: comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops.Review: corneal epithelial stem cells, their niche and wound healing.Cord blood serum-based eye drops: the impact of donor haematological and obstetric factors on the variability of epidermal growth factor levels.Effect of tyrosine kinase inhibitors on wound healing and tissue repair: implications for surgery in cancer patients.
P2860
Posology, efficacy, and safety of epidermal growth factor eye drops in 305 patients: logistic regression and group-wise odds of published data.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Posology, efficacy, and safety ...... p-wise odds of published data.
@ast
Posology, efficacy, and safety ...... p-wise odds of published data.
@en
Posology, efficacy, and safety ...... p-wise odds of published data.
@nl
type
label
Posology, efficacy, and safety ...... p-wise odds of published data.
@ast
Posology, efficacy, and safety ...... p-wise odds of published data.
@en
Posology, efficacy, and safety ...... p-wise odds of published data.
@nl
prefLabel
Posology, efficacy, and safety ...... p-wise odds of published data.
@ast
Posology, efficacy, and safety ...... p-wise odds of published data.
@en
Posology, efficacy, and safety ...... p-wise odds of published data.
@nl
P2093
P356
P1476
Posology, efficacy, and safety ...... p-wise odds of published data.
@en
P2093
Elena Bonafonte-Marquez
Pedro A Martínez-Carpio
Sergio Bonafonte-Royo
P304
P356
10.1089/JOP.2011.0236
P577
2012-04-26T00:00:00Z